The efficacy of quadruple therapy in non-ulcer Helicobacter Pylory gastritis in children: A prospective study
Keywords:
children, esomeprazole, gastritis, Helicobacter pylori, quadruple therapyAbstract
Aim: To compare the clinical improvement of two-regimen treatment using esomeprazole alone vs quadruple therapy in non-ulcer Helicobacter Pylori (H. pylori) gastritis in Vietnamese’s children.
Methods: A prospective study, carried out in 52 children, 5 to 11 years old, receive a quadruple therapy including 2 mg/kg/day esomeprazole, bismuth 8 mg/kg/day, amoxicillin 100 mg/kg/day and metronidazole 25 mg/kg/day for the first two weeks, then 2 mg/kg/day esomeprazole for the other two weeks.
Results: Asymptomatic children after one month of treatment stopping were found in 34 children (58.6%). H. pylori eradication rate in intention to treat and per-protocol analysis showed a 31/55 (56.4%) and 31/52 (59.6%) patients after four weeks of treatment stopping.
Conclusion: Quadruple regimen even with high dose of esomeprazole and amoxicillin combined metronidazole and bismuth showed a lower eradication rate and did not achieve the usual recommended rate > 90%.
Downloads
References
Gao C, Du SY, Fang L, Fan YH, Song AP, Chen H. Eradication treatment of Helicobacter pylori infection based on molecular pathologic antibiotic resistance. Infection drug resistance. 2020;13:69. DOI: 10.2147/IDR.S232169.
Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut. 2010;59(8):1143-53. DOI: 10.1136/gut.2009.192757.
Kato S, Shimizu T, Toyoda S, Gold BD, Ida S, Ishige T, et al. The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood. J Pediatrics International. 2020;62(12):1315. DOI: 10.1111/ped.14388
Jones NL, Koletzko S, Goodman K, Bontems P, Cadranel S, Casswall T, et al. Joint ESPGHAN/NASPGHAN guidelines for the management of Helicobacter pylori in children and adolescents (update 2016). Journal of Pediatric Gastroenterology Nutrition 2017;64(6):991-1003. DOI: 10.1097/MPG.0000000000001594.
Jun JS, Seo JH, Park JS, Rhee KH, Youn HS. Changes in the treatment strategies for Helicobacter pylori infection in children and adolescents in Korea. Pediatric gastroenterology, hepatology nutrition. 2019;22(5):417. DOI: 10.5223/pghn.2019.22.5.417.
Koletzko S, Jones NL, Goodman KJ, Gold B, Rowland M, Cadranel S, et al. Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. Journal of Pediatric Gastroenterology and Nutrition 2011;53(2):230-43. DOI: 10.1097/MPG.0b013e3182227e90
Sipponen P, Price AB, Hepatology. The Sydney System for classification of gastritis 20 years ago. Journal of Gastroenterology Hepatology. 2011;26:31-4. DOI: 10.1111/j.1440-1746.2010.06536.x.
da Silva FAF, de Brito BB, Santos MLC, Marques HS, Sampaio MM, da Silva Júnior RT, et al. Treatment of Helicobacter pylori infection in children: A systematic review. World Journal of Meta Analysis. 2020;8(4):292-308. DOI: 10.13105/wjma.v8.i4.292.
Bahremand S, Nematollahi LR, Fourutan H, Tirgari F, Nouripour S, Mir E, et al. Evaluation of triple and quadruple Helicobacter pylori eradication therapies in Iranian children: a randomized clinical trial. European journal of gastroenterology hepatology. 2006;18(5):511-4. DOI: 10.1097/00042737-200605000-00009.
Farahmand F, Mohammadi T, Najafi M, Fallahi G, Khodadad A, Motamed F, et al. Comparison of ciprofloxacin-based triple therapy with conventional triple regimen for Helicobacter pylori eradication in children. Acta Medica Iranica. 2016 [access: 21/03/2024];54(6):395-400. Available from: https://pubmed.ncbi.nlm.nih.gov/27306347/
Khodadad A, Farahmand F, Najafi M, Shoaran M. Probiotics for the treatment of pediatric helicobacter pylori infection: a randomized double blind clinical trial. Iranian journal of pediatrics. 2013 [access: 17/04/2024]; 23(1):79-84. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574996/
Moubri M, Kalach N, Larras R, Berrah H, Mouffok F, Guechi Z, et al. Adapted first-line treatment of Helicobacter pylori infection in Algerian children. Annals of gastroenterology. 2019;32(1):60. DOI: 10.20524/aog.2018.0317
Esmaeili-Dooki MR, Shirdel H, Hajiahmadi M. Eradication of Helicobacter pylori in children by triple therapy regimens of amoxicillin, omeprazole, and clarithromycin or azithromycin. Iranian journal of pediatrics. 2015;25(6):e2360. DOI: 10.5812/ijp.2360
Akcam M, Koca T, Salman H, Karahan N. The effects of probiotics on treatment of Helicobacter pylori eradication in children. Saudi medical journal 2015;36(3):286. DOI: 10.15537/smj.2015.3.10124
Tümgör G, Baran M, Çakir M, Yüksekkaya HA, Aydogdu S. Comparison of standard and standard plus vitamin E therapy for Helicobacter pylori eradications in children. Turk J Gastroenterol. 2014;25(1):99-103. DOI: 10.5152/tjg.2014.5592
Tolone S, Pellino V, Vitaliti G, Tolone C. Evaluation of Helicobacter Pylori eradication in pediatric patients by triple therapy plus lactoferrin and probiotics compared to triple therapy alone. Italian journal of pediatrics. 2012;38(1):1-5. DOI: 10.1186/1824-7288-38-63
Francavilla R, Lionetti E, Castellaneta SP, Magistà AM, Boscarelli G, Piscitelli D, et al. Improved efficacy of 10-day sequential treatment for Helicobacter pylori eradication in children: a randomized trial. Gastroenterology. 2005;129(5):1414-9. DOI: 10.1053/j.gastro.2005.09.007
Kotilea K, Kalach N, Homan M, Bontems P. Helicobacter pylori infection in pediatric patients: update on diagnosis and eradication strategies. Pediatric Drugs. 2018;20(4):337-51. DOI: 10.1007/s40272-018-0296-y
Nguyen TVH, Bengtsson C, Yin L, Nguyen GK, Hoang TTH, Phung DC, et al. Eradication of Helicobacter pylori in children in Vietnam in relation to antibiotic resistance. Helicobacter. 2012;17(4):319-25. DOI: 10.1111/j.1523-5378.2012.00950.x
Nguyen CT, Robert A, Pham THA, Vo HK, Le LD, Ma HT et al. Helicobacter pylori Eradication Rate Using Stool Antigen Test in Vietnamese Children: A Prospective Multicenter Study. JPGN Rep. 2023 Nov; 4(4): e374. DOI: 10.1097/PG9.0000000000000374
Huang J, Zhou L, Geng L, Yang M, Xu XW, Ding ZL, et al. Randomised controlled trial: sequential vs. standard triple therapy for H elicobacter pylori infection in Chinese children-a multicentre, open-labelled study. Alimentary pharmacology therapeutics. 2013;38(10):1230-5. DOI: 10.1111/apt.12516
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Hien Thi Phan, Ngoan Thi Dao, Phuong Minh Nguyen, Phu Huy Nguyen, Ha Thu Nguyen, Linh Thi Thuy Nguyen
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who have publications with this Journal accept the following terms:
- The authors will retain their copyright and guarantee the Journal the right of first publication of their work, which will simultaneously be subject to the Creative Commons Attribution License. The content presented here can be shared, copied and redistributed in any medium or format; Can be adapted, remixed, transformed or created from the material, using the following terms: Attribution (giving appropriate credit to the work, providing a link to the license, and indicating if changes have been made); non-commercial (you cannot use the material for commercial purposes) and share-alike (if you remix, transform or create new material from this work, you can distribute your contribution as long as you use the same license as the original work).
- The authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (for example: depositing it in an institutional electronic archive or publishing it in a monographic volume) as long as the initial publication in this Journal is indicated.
- Authors are allowed and recommended to disseminate their work through the Internet (e.g., in institutional electronic archives or on their website) before and during the submission process, which can produce interesting exchanges and increase citations. of the published work.
